Company: BIVIW
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001520138-25-000144
Chunk: 10

Company: BIOVIE INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 10
---
 2,901,341  
     (7,500,000)
  
    Payment of loan premium 
     (850,000) 
     - 
  
    Payments of note payable 
     (5,000,000) 
     - 
  
    Net cash provided by financing activities 
     12,725,954  
     20,302,939 

    Net change in cash and cash equivalents 
     (691,784) 
     10,889,454 

    Cash and cash equivalents, beginning of period 
    $23,843,798  
    $19,460,883 

    Cash and cash equivalents, end of period 
    $23,152,014  
    $30,350,337 

    SUPPLEMENTAL CASH FLOW INFORMATION: 

    Cash paid for interest 
    $178,932  
    $1,293,419 

    SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING ACTIVITIES: 

    Right of use assets obtained in exchange for lease obligations 
    $-  
    $432,192 
  
    Reclassification of unrealized gains on U.S. Treasury Bills (available-for-sale investments) upon settlement 
    $-  
    $176,591 
  
    Deemed dividend for ratchet adjustment to warrants 
    $369,465  
    $886,423 

See accompanying notes to unaudited condensed financial
statements

 7 

BioVie Inc.

Notes to Condensed Financial Statements

For the Three and Nine Months Ended March 31, 2025
and 2024

(unaudited)

    1.
    Background Information

BioVie Inc. (the “Company” or “we”
or “our”) is a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including
neurological and neuro-degenerative disorders and liver disease. 

The Company acquired the biopharmaceutical assets of NeurMedix, Inc.
(“NeurMedix”) a privately held clinical-stage pharmaceutical company and a related party in June 2021. The acquired
assets included NE3107 or (“bezisterim”). Bezisterim, the approved generic name for NE3107 is an investigational, novel, orally
administered small molecule that is thought to inhibit inflammation-driven insulin resistance and major pathological inflammatory cascades